403 related articles for article (PubMed ID: 28322415)
21. Norepinephrine or dopamine for septic shock: systematic review of randomized clinical trials.
Vasu TS; Cavallazzi R; Hirani A; Kaplan G; Leiby B; Marik PE
J Intensive Care Med; 2012; 27(3):172-8. PubMed ID: 21436167
[TBL] [Abstract][Full Text] [Related]
22. Early Vasopressor Utilization Strategies and Outcomes in Critically Ill Patients With Severe Traumatic Brain Injury.
Toro C; Ohnuma T; Komisarow J; Vavilala MS; Laskowitz DT; James ML; Mathew JP; Hernandez AF; Goldstein BA; Sampson JH; Krishnamoorthy V
Anesth Analg; 2022 Dec; 135(6):1245-1252. PubMed ID: 35203085
[TBL] [Abstract][Full Text] [Related]
23. Fluid administration in severe sepsis and septic shock, patterns and outcomes: an analysis of a large national database.
Marik PE; Linde-Zwirble WT; Bittner EA; Sahatjian J; Hansell D
Intensive Care Med; 2017 May; 43(5):625-632. PubMed ID: 28130687
[TBL] [Abstract][Full Text] [Related]
24. Early prediction of norepinephrine dependency and refractory septic shock with a multimodal approach of vascular failure.
Conrad M; Perez P; Thivilier C; Levy B
J Crit Care; 2015 Aug; 30(4):739-43. PubMed ID: 25900257
[TBL] [Abstract][Full Text] [Related]
25. Serious adverse events associated with vasopressin and norepinephrine infusion in septic shock.
Anantasit N; Boyd JH; Walley KR; Russell JA
Crit Care Med; 2014 Aug; 42(8):1812-20. PubMed ID: 24919159
[TBL] [Abstract][Full Text] [Related]
26. Efficacy and Safety of Vasopressin as First-Line Treatment of Distributive and Hemorrhagic Shock States.
Haan BJ; Cadiz ML; Natavio AM
Ann Pharmacother; 2020 Mar; 54(3):213-218. PubMed ID: 31625395
[No Abstract] [Full Text] [Related]
27. Evaluating Vasopressor Discontinuation Strategies in Patients With Septic Shock on Concomitant Norepinephrine and Vasopressin Infusions.
Musallam N; Altshuler D; Merchan C; Zakhary B; Aberle C; Papadopoulos J
Ann Pharmacother; 2018 Aug; 52(8):733-739. PubMed ID: 29560736
[TBL] [Abstract][Full Text] [Related]
28. Dopamine therapy in septic shock: detrimental effect on survival?
Boulain T; Runge I; Bercault N; Benzekri-Lefevre D; Wolf M; Fleury C
J Crit Care; 2009 Dec; 24(4):575-82. PubMed ID: 19327324
[TBL] [Abstract][Full Text] [Related]
29. Efficacy and safety of dopamine versus norepinephrine in the management of septic shock.
Patel GP; Grahe JS; Sperry M; Singla S; Elpern E; Lateef O; Balk RA
Shock; 2010 Apr; 33(4):375-80. PubMed ID: 19851126
[TBL] [Abstract][Full Text] [Related]
30. Intensity of Vasopressor Therapy for Septic Shock and the Risk of In-Hospital Death.
Brand DA; Patrick PA; Berger JT; Ibrahim M; Matela A; Upadhyay S; Spiegler P
J Pain Symptom Manage; 2017 May; 53(5):938-943. PubMed ID: 28062334
[TBL] [Abstract][Full Text] [Related]
31. Impact of Norepinephrine Weight-Based Dosing Compared With Non-Weight-Based Dosing in Achieving Time to Goal Mean Arterial Pressure in Obese Patients With Septic Shock.
Vadiei N; Daley MJ; Murthy MS; Shuman CS
Ann Pharmacother; 2017 Mar; 51(3):194-202. PubMed ID: 27886982
[TBL] [Abstract][Full Text] [Related]
32. Delayed vasopressor initiation is associated with increased mortality in patients with septic shock.
Colon Hidalgo D; Patel J; Masic D; Park D; Rech MA
J Crit Care; 2020 Feb; 55():145-148. PubMed ID: 31731173
[TBL] [Abstract][Full Text] [Related]
33. Low-dose corticosteroid treatment in septic shock: a propensity-matching study.
Funk D; Doucette S; Pisipati A; Dodek P; Marshall JC; Kumar A;
Crit Care Med; 2014 Nov; 42(11):2333-41. PubMed ID: 25072758
[TBL] [Abstract][Full Text] [Related]
34. Mortality Measures to Profile Hospital Performance for Patients With Septic Shock.
Walkey AJ; Shieh MS; Liu VX; Lindenauer PK
Crit Care Med; 2018 Aug; 46(8):1247-1254. PubMed ID: 29727371
[TBL] [Abstract][Full Text] [Related]
35. Norepinephrine and Vasopressin Compared With Norepinephrine and Epinephrine in Adults With Septic Shock.
Menich BE; Miano TA; Patel GP; Hammond DA
Ann Pharmacother; 2019 Sep; 53(9):877-885. PubMed ID: 30957512
[No Abstract] [Full Text] [Related]
36. Analysis of Mortality in Patients Treated With Phenylephrine in Septic Shock.
Patel VV; Sullivan JB; Cavanaugh J
J Pharm Pract; 2023 Feb; 36(1):15-18. PubMed ID: 33752492
[TBL] [Abstract][Full Text] [Related]
37. Diastolic arterial blood pressure: a reliable early predictor of survival in human septic shock.
Benchekroune S; Karpati PC; Berton C; Nathan C; Mateo J; Chaara M; Riché F; Laisné MJ; Payen D; Mebazaa A
J Trauma; 2008 May; 64(5):1188-95. PubMed ID: 18469640
[TBL] [Abstract][Full Text] [Related]
38. Norepinephrine in Septic Shock: A Systematic Review and Meta-analysis.
Ruslan MA; Baharuddin KA; Noor NM; Yazid MB; Noh AYM; Rahman A
West J Emerg Med; 2021 Feb; 22(2):196-203. PubMed ID: 33856300
[TBL] [Abstract][Full Text] [Related]
39. Days alive and free as an alternative to a mortality outcome in pivotal vasopressor and septic shock trials.
Russell JA; Lee T; Singer J; De Backer D; Annane D
J Crit Care; 2018 Oct; 47():333-337. PubMed ID: 29958734
[TBL] [Abstract][Full Text] [Related]
40. Severe sepsis and septic shock in patients with pre-existing non-cardiac pulmonary hypertension: contemporary management and outcomes.
Tsapenko MV; Herasevich V; Mour GK; Tsapenko AV; Comfere TB; Mankad SV; Cartin-Ceba R; Gajic O; Albright RC
Crit Care Resusc; 2013 Jun; 15(2):103-9. PubMed ID: 23931041
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
